A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
Clinical trial NCT04970901 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04970901
- Sponsor
- ADC Therapeutics S.A.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-17
- Primary completion
- 2027-03-31
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.